Lymphoma staging

Xem 1-19 trên 19 kết quả Lymphoma staging
  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Bronchus-associated lymphoid tissue lymphoma stage IV with subsequent histologic transformation to an aggressive lymphoma: A case report

    pdf4p toshiba24 07-12-2011 29 2   Download

  • The combination of functional metabolic information and anatomical data has been available since 2001, when the combined PET/CT scanner was introduced. This technology has had a significant impact on many medical disciplines, including cardiology and neurology, but undoubtedly the greatest impact has been in the field of oncological imaging. It is the ability of PET/CT to accurately identify the anatomical location of abnormal metabolic activity that has revolutionized the detection and staging of many tumors....

    pdf249p waduroi 03-11-2012 27 9   Download

  • The field of general surgery has changed dramatically over the last ten years with the acceptance of laparoscopy as an extension of the scalpel. Once ridiculed by most academic centers, laparoscopy has revolutionized the management of biliary tract disease and has led to a critical reassessment of how patients with other general surgical problems are managed. The rapid advancement and acceptance of laparoscopy as a part of general surgery is apparent today since most academic centers have laparoscopic sections and many offer laparoscopic fellowships....

    pdf257p tom_123 15-11-2012 27 6   Download

  • Cancers of the oropharynx often metastasize to upper and middle jugular chain lymph nodes (Levels II and III), but can also spread to retropharyngeal lymph nodes, which distinguishes them from oral cavity tumors and must be considered when treating oropharyngeal cancers. Tumors in this site are generally treated with radiotherapy, as a single modality for T 1/2 or N 0/1 stages. Increas- ingly, some of these cancers are associated with human papilloma virus 16 infection, especially in nonsmokers.

    pdf53p taisaokhongthedung 07-01-2013 17 3   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài:Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International

    pdf9p toshiba24 06-12-2011 32 2   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài:Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy?

    pdf6p toshiba24 06-12-2011 12 2   Download

  • Average annual age-adjusted cancer incidence rates were calculated for each poverty area group in New Jersey. Included in the report are the average annual age-adjusted incidence rates per 100,000 population for all types of cancer combined and 16 cancers that are the most common types among men and/or women, or among the leading causes of cancer death.

    pdf0p khongmuonnghe 07-01-2013 23 1   Download

  • Harrison's Internal Medicine Chapter 95. Carcinoma of Unknown Primary Carcinoma of Unknown Primary: Introduction Carcinoma of unknown primary (CUP) is a biopsy-proven (mainly epithelial) malignancy for which the anatomic site of origin remains unidentified after an intensive search. CUP is one of the 10 most frequently diagnosed cancers worldwide, accounting for approximately 3–5% of all cancer cases.

    pdf5p thanhongan 07-12-2010 42 5   Download

  • Staging As noted in Chap. 77, an important component of patient management is defining the extent of disease. Radiographic and other imaging tests can be helpful in defining the clinical stage; however, pathologic staging requires defining the extent of involvement by documenting the histologic presence of tumor in tissue biopsies obtained through a surgical procedure.

    pdf5p konheokonmummim 03-12-2010 30 3   Download

  • Harrison's Internal Medicine Chapter 105. Malignancies of Lymphoid Cells Malignancies of Lymphoid Cells: Introduction Malignancies of lymphoid cells range from the most indolent to the most aggressive human malignancies. These cancers arise from cells of the immune system at different stages of differentiation, resulting in a wide range of morphologic, immunologic, and clinical findings. Insights on the normal immune system have allowed a better understanding of these sometimes confusing disorders. Some malignancies of lymphoid cells almost always present as leukemia (i.e.

    pdf5p thanhongan 07-12-2010 41 3   Download

  • Pathway of normal T cell differentiation and relationship to T cell lymphomas. CD1, CD2, CD3, CD4, CD5, CD6, CD7, CD8, CD38, and CD71 are cell markers used to distinguish stages of development. T cell antigen receptors (TCR) rearrange in the thymus, and mature T cells emigrate to nodes and peripheral blood. ALL, acute lymphoid leukemia; T-ALL, T cell ALL; T-LL, T cell lymphoblastic lymphoma; T-CLL, T cell chronic lymphoid leukemia; CTCL, cutaneous T cell lymphoma; NHL, non-Hodgkin's lymphoma.

    pdf5p thanhongan 07-12-2010 32 3   Download

  • Two other features may be used to assess prognosis in B cell CLL, but neither has yet been incorporated into a staging classification. At least two subsets of CLL have been identified based on the cytoplasmic expression of ZAP-70; expression of this protein, which is usually expressed in T cells, identifies a subgroup with poorer prognosis. A less powerful subsetting tool is CD38 expression. CD38+ tumors tend to have a poorer prognosis than CD38– tumors. The initial evaluation of a patient with Hodgkin's disease or non-Hodgkin's lymphoma is similar.

    pdf5p thanhongan 07-12-2010 21 3   Download

  • Table 105-9 International Prognostic Index for NHL Five clinical risk factors: Age ≥60 years Serum lactate dehydrogenase levels elevated Performance status ≥2 (ECOG) or ≤70 (Karnofsky) Ann Arbor stage III or IV 1 site of extranodal involvement Patients are assigned a number for each risk factor they have Patients are grouped differently based upon the type of lymphoma For diffuse large B cell lymphoma: 0, 1 factor = low risk: 73% 35% of cases; 5-year survival, 2 factors = low-intermediate risk: 51% 27% of cases; 5-year survival, 3 factors = high-intermediate risk: 43%...

    pdf5p thanhongan 07-12-2010 32 3   Download

  • B Cell Chronic Lymphoid Leukemia/Small Lymphocytic Lymphoma: Treatment Patients whose presentation is typical B cell CLL with no manifestations of the disease other than bone marrow involvement and lymphocytosis (i.e., Rai stage O and Binet stage A; Table 105-7) can be followed without specific therapy for their malignancy. These patients have a median survival 10 years, and some will never require therapy for this disorder.

    pdf5p thanhongan 07-12-2010 32 3   Download

  • Evaluation of patients with MALT lymphoma follows the pattern (Table 105-11) for staging a patient with non-Hodgkin's lymphoma. In particular, patients with gastric lymphoma need to have studies performed to document the presence or absence of H. pylori infection. Endoscopic studies including ultrasound can help define the extent of gastric involvement. Most patients with MALT lymphoma have a good prognosis, with a 5-year survival of ~75%. In patients with a low IPI score, the 5-year survival is ~90%, while it drops to ~40% in patients with a high IPI score.

    pdf5p thanhongan 07-12-2010 30 3   Download

  • Carcinoma of unknown primary (CUP) is a biopsy-proven (mainly epithelial) malignancy for which the anatomic site of origin remains unidentified after an intensive search. CUP is one of the 10 most frequently diagnosed cancers worldwide, accounting for approximately 3–5% of all cancer cases. Most investigators do not consider lymphomas, metastatic melanomas, and metastatic sarcomas that present without a known primary tumor to be CUP because these cancers have specific stage- and histology-based treatments that can guide management. ...

    pdf9p socolanong 25-04-2012 38 3   Download

  • Rare patients with localized early stage mycosis fungoides can be cured with radiotherapy, often total-skin electron beam irradiation. More advanced disease has been treated with topical glucocorticoids, topical nitrogen mustard, phototherapy, psoralen with ultraviolet A (PUVA), electron beam radiation, interferon, antibodies, fusion toxins, and systemic cytotoxic therapy. Unfortunately, these treatments are palliative. Adult T Cell Lymphoma/Leukemia Adult T cell lymphoma/leukemia is one manifestation of infection by the HTLV-I retrovirus.

    pdf5p thanhongan 07-12-2010 15 2   Download

  • Malignancies of lymphoid cells range from the most indolent to the most aggressive human malignancies. These cancers arise from cells of the immune system at different stages of differentiation, resulting in a wide range of morphologic, immunologic, and clinical findings. Insights on the normal immune system have allowed a better understanding of these sometimes confusing disorders. Some malignancies of lymphoid cells almost always present as leukemia (i.e., primary involvement of bone marrow and blood), while others almost always present as lymphomas (i.e.

    pdf40p ozon_ozon 26-04-2012 27 2   Download

  • Chemotherapy for lymphoma uses drugs to kill lymphoma cells. It is called systemic therapy because the drugs travel through the bloodstream. The drugs can reach lymphoma cells in almost all parts of the body. You may receive chemotherapy by mouth, through a vein, or in the space around the spinal cord. Treatment is usually in an outpatient part of the hospital, at the doctor’s office, or at home. Some people need to stay in the hospital during treatment. Chemotherapy is given in cycles. You have a treatment period followed by a rest period.

    pdf0p taisaokhongthedung 07-01-2013 12 2   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản